Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 8, 2010, Pages 1213-1218

  Gaba, Ron C ^a   Riaz, Ahsun ^b   Lewandowski, Robert J ^b   Ibrahim, Saad M ^b   Ryu, Robert K ^b   Sato, Kent T ^b   Omary, Reed A ^b   Salem, Riad ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

alkaline phosphatase; ALP; HCC; hepatocellular carcinoma; WBC; white blood cell

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; MICROSPHERE; YTTRIUM 90; BIOLOGICAL MARKER; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; BREAST CARCINOMA; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE; LIVER TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; BLOOD; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CHOLESTASIS; COMPLICATION; LEUKOCYTE COUNT; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; TIME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BILIRUBIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHICAGO; CHOLESTASIS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LEUKOCYTE COUNT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROSPHERES; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM;

EID: 77955714161     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.04.013     Document Type: Article

References (17)

1. R. Salem, and K.G. Thurston Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278 (Pubitemid 44259009)
2. R. Salem, and K.G. Thurston Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 2: special topics J Vasc Interv Radiol 17 2006 1425 1439 (Pubitemid 44412994)
3. R. Salem, and K.G. Thurston Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction J Vasc Interv Radiol 17 2006 1571 1593 (Pubitemid 44596135)
4. B. Atassi, A.K. Bangash, and R.J. Lewandowski Biliary sequelae following radioembolization with yttrium-90 microspheres J Vasc Interv Radiol 19 2008 691 697
5. R.L. Baron, R.J. Stanley, J.K. Lee, R.E. Koehler, and R.G. Levitt Computed tomographic features of biliary obstruction AJR Am J Roentgenol 140 1983 1173 1178
6. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
7. J. Bruix, M. Sherman, J.M. Llovet European Association for the Study of the Liver Clinical management of hepatocellular carcinoma Conclusions of the Barcelona 2000 EASL conference J Hepatol 35 2001 421 430
8. R.J. Lewandowski, K.T. Sato, and B. Atassi Radioembolization with (90)y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 2007 571 592 (Pubitemid 350092259)
9. I. Sakamoto, S. Iwanaga, and K. Nagaoki Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization AJR Am J Roentgenol 181 2003 79 87
10. S.Y. Song, J.W. Chung, and J.K. Han Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome J Vasc Interv Radiol 12 2001 131 320
11. J.L. Doppman, M. Girton, and M. Vermess The risk of hepatic artery embolization in the presence of obstructive jaundice Radiology 143 1982 37 43
12. H.K. Kim, Y.H. Chung, and B.C. Song Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma J Clin Gastroenterol 32 2001 423 427
13. J.F. Geschwind, S. Kaushik, D.E. Ramsey, M.A. Choti, E.K. Fishman, and H. Kobeiter Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors J Vasc Interv Radiol 13 2002 1163 1166
14. J.M. Kiely, W.S. Rilling, and J.G. Touzios Chemoembolization in patients at high risk: results and complications J Vasc Interv Radiol 17 2006 47 53
15. S. Patel, C.M. Tuite, J.I. Mondschein, and M.C. Soulen Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention J Vasc Interv Radiol 17 2006 1931 1934
16. K. Sato, R.J. Lewandowski, and J.T. Bui Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere(R)): assessment of hepatic arterial embolization Cardiovasc Intervent Radiol 29 2006 522 529
17. R. Murthy, H. Xiong, and R. Nunez Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results J Vasc Interv Radiol 16 2005 937 945